Lepirudina (Italian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Lepirudina" in Italian language version.

refsWebsite

Global rank Italian rank

2^nd place

7^th place

4^th place

9^th place

low place

low place

68^th place

57^th place

1web.archive.org

1^st place

1^st place

610^th place

820^th place

447^th place

644^th place

low place

4,124^th place

doi.org

dx.doi.org

Sirak Petros, Lepirudin in the management of patients with heparin-induced thrombocytopenia, in Biologics: Targets & Therapy, vol. 2, n. 3, 2008-09, pp. 481–490, DOI:10.2147/btt.s3415. URL consultato il 15 luglio 2023.
N. Lubenow, P. Eichler e T. Lietz, Lepirudin in patients with heparin-induced thrombocytopenia - results of the third prospective study (HAT-3) and a combined analysis of HAT-1, HAT-2, and HAT-3, in Journal of thrombosis and haemostasis: JTH, vol. 3, n. 11, 2005-11, pp. 2428–2436, DOI:10.1111/j.1538-7836.2005.01623.x. URL consultato il 15 luglio 2023.
(EN) John C. Chapin e Katherine A. Hajjar, Fibrinolysis and the control of blood coagulation, in Blood Reviews, vol. 29, n. 1, 2015-01, pp. 17–24, DOI:10.1016/j.blre.2014.09.003. URL consultato il 15 luglio 2023.

drugbank.com

go.drugbank.com

Lepirudin, su go.drugbank.com. URL consultato il 15 luglio 2023.

elsevier.com

linkinghub.elsevier.com

(EN) John C. Chapin e Katherine A. Hajjar, Fibrinolysis and the control of blood coagulation, in Blood Reviews, vol. 29, n. 1, 2015-01, pp. 17–24, DOI:10.1016/j.blre.2014.09.003. URL consultato il 15 luglio 2023.

europa.eu

ema.europa.eu

EMA Summary of Product Characteristics: Refludan (lepirudin) powder for intravenous injection or infusion (PDF), su ema.europa.eu.

fda.gov

accessdata.fda.gov

FDA Clinical Pharmacology and Biopharmaceutics Review: Refludan (lepirudin) lyophilized powder for intravenous injection (PDF), su accessdata.fda.gov.

hres.ca

pdf.hres.ca

Health Canada Approved Drug Products: Refludan (lepirudin) lyophilized powder for intravenous injection (PDF), su pdf.hres.ca.

nih.gov

pubmed.ncbi.nlm.nih.gov

Sirak Petros, Lepirudin in the management of patients with heparin-induced thrombocytopenia, in Biologics: Targets & Therapy, vol. 2, n. 3, 2008-09, pp. 481–490, DOI:10.2147/btt.s3415. URL consultato il 15 luglio 2023.
N. Lubenow, P. Eichler e T. Lietz, Lepirudin in patients with heparin-induced thrombocytopenia - results of the third prospective study (HAT-3) and a combined analysis of HAT-1, HAT-2, and HAT-3, in Journal of thrombosis and haemostasis: JTH, vol. 3, n. 11, 2005-11, pp. 2428–2436, DOI:10.1111/j.1538-7836.2005.01623.x. URL consultato il 15 luglio 2023.

web.archive.org

Bayer HealthCare: Discontinuation of Refludan [lepirudin (rDNA) for injection] (PDF), su hrsa.gov. URL consultato il 15 luglio 2023 (archiviato dall'url originale il 5 marzo 2022).